CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Intravitreal Bevacizumab (Avastin) as an Adjuvant for the Treatment of Posterior Scleritis
Ji Won Lim, Joo Hyun Park
Korean J Ophthalmol. 2011;25(4):282-284.   Published online July 22, 2011
DOI: https://doi.org/10.3341/kjo.2011.25.4.282

Excel Download

Intravitreal Bevacizumab (Avastin) as an Adjuvant for the Treatment of Posterior Scleritis
Korean Journal of Ophthalmology. 2011;25(4):282   Crossref logo
Link1 Link2 Link3

Intravitreal bevacizumab (AVASTIN®) in the treatment of diabetic macular oedema
Acta Ophthalmologica. 2010;88:0-0   Crossref logo
Link1 Link2

Intravitreal bevacizumab (Avastin) for primary treatment of diabetic macular oedema
Eye. 2008;23(3):616-620   Crossref logo
Link1 Link2 Link3

Intravitreal Bevacizumab (Avastin®) in the Treatment of Neovascular Glaucoma
Yearbook of Ophthalmology. 2007;2007:95-96   Crossref logo
Link1 Link2

Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy
Yearbook of Ophthalmology. 2007;2007:125-126   Crossref logo
Link1 Link2

Intravitreal Injection of Bevacizumab (Avastin) as Adjunctive Treatment of Proliferative Diabetic Retinopathy
Yearbook of Ophthalmology. 2007;2007:125-126   Crossref logo
Link1 Link2

Treatment of a vasoproliferative tumour with intravitreal bevacizumab (Avastin)
Eye. 2007;21(6):893-894   Crossref logo
Link1 Link2 Link3

Intravitreal bevacizumab (Avastin) treatment is safe in terms of intraocular and blood pressure
Acta Ophthalmologica Scandinavica. 2006;85(1):119-120   Crossref logo
Link1 Link2

Pharmacokinetics of Intravitreal Bevacizumab (Avastin)
Yearbook of Ophthalmology. 2008;2008:144-145   Crossref logo
Link1 Link2

Intravitreal bevacizumab (Avastin) treatment in neovascular age-related macular degeneration: 6 months results
Acta Ophthalmologica. 2008;86:0-0   Crossref logo
Link1 Link2